Health In Tech, Inc. (HIT) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Health In Tech, Inc. (HIT) stock forecast summary
Our AI ranks Health In Tech, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Health In Tech, Inc. is a small-cap company with a market capitalization of $47M. It ranks number 19 by market capitalization among the 22 Insurance Agents, Brokers & Service issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for HIT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, HIT included.
Follow HIT freeHIT price chart and AI forecast
How HIT ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Health In Tech, Inc. (HIT) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Insurance Agents, Brokers & Service peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | HIT | Rank |
|---|---|---|
| Market Cap | $47M | 19/22 |
| P/B Ratio | 2.41x | 12/16 |
| EPS | $-0.03 | – |
| Book Value/Share | $0.30 | – |
| Revenue/Share | $0.50 | – |
Profitability & Margins
| Metric | HIT | Rank |
|---|---|---|
| Gross Margin | 53.9% | 2/7 |
| EBT Margin | -15.9% | 19/22 |
| Tax Rate | 24.5% | – |
Financial Health
| Metric | HIT | Rank |
|---|---|---|
| Current Ratio | 2.18x | 4/20 |
| D/E Ratio | 0.51x | 17/20 |
| Financial Leverage | 1.52x | 18/20 |
| Working Capital | $12M | 12/18 |
Cash Flow
| Metric | HIT | Rank |
|---|---|---|
| Operating Cash Flow | -$5M | 21/23 |
Operational Efficiency
| Metric | HIT | Rank |
|---|---|---|
| Asset Turnover | 1.11x | 8/22 |
| Receivables Turnover | 3.8x | 10/13 |
| Days Sales Outstanding | 95 days | 4/13 |
Income Statement
| Metric | HIT | Rank |
|---|---|---|
| Total Revenue | $32M | 19/21 |
| R&D Expense | $2M | – |
| SG&A Expense | $24M | 5/6 |
| Cost of Goods Sold | $15M | 7/8 |
Dividend & Shareholder Information
| Metric | HIT | Rank |
|---|---|---|
| Shares Outstanding | 66M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $22M | 73.6% of assets |
| Cash & Short-term Investments | $7M | 22.0% of assets |
| Accounts Receivable | $9M | 28.9% of assets |
| Total Liabilities | $10M | 33.8% of assets |
HIT quarterly financials and insider trading
Health In Tech, Inc. (HIT) industry peers
Companies classified under the same SEC industry code as Health In Tech, Inc. (Insurance Agents, Brokers & Service): 26 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| HIT Health In Tech, Inc. | ▲ | $47M |
| MRSH Marsh & Mclennan Companies, Inc. | ▼ | $84.47B |
| AJG Arthur J. Gallagher & Co. | ▼ | $59.69B |
| AON Aon Plc | ▼ | $58.27B |
| BRO Brown & Brown, Inc. | ▶ | $21.43B |
| EQH Equitable Holdings, Inc. | ▼ | $14.50B |
| ERIE Erie Indemnity Co | ▲ | $10.66B |
| ACT Enact Holdings, Inc. | ▶ | $6.18B |
| HGTY Hagerty, Inc. | ▲ | $5.15B |
| BWIN Baldwin Insurance Group, Inc. | ▼ | $4.45B |
| ARX Accelerant Holdings | ▼ | $4.29B |
| NP Neptune Insurance Holdings Inc. | ▲ | $4.00B |
| CRVL Corvel Corp | ▲ | $3.98B |
| GSHD Goosehead Insurance, Inc. | ▲ | $1.58B |
| TWFG Twfg, Inc. | ▲ | $1.32B |
| HUIZ Huize Holding Ltd | ▲ | $1.30B |
| CRD-A Crawford & Co | ▲ | $608M |
| RDZN Roadzen Inc. | ▲ | $95M |
| SLQT Selectquote, Inc. | ▲ | $62M |
| EHTH Ehealth, Inc. | ▲ | $21M |
| CCG Cheche Group Inc. | ▶ | $11M |
| EZRA Reliance Global Group, Inc. | ▲ | $2M |
| AAPI Apple Isports Group, Inc. | ▼ | N/A |
| QDMI Qdm International Inc. | ▼ | N/A |
| RYAN Ryan Specialty Holdings, Inc. | ▶ | N/A |
| SUND Sundance Strategies, Inc. | ▼ | N/A |
Where HIT sits on the market map
Health In Tech, Inc. (HIT) stock news
Loading...
Health In Tech, Inc. (HIT) stock forecast FAQ
What is the Health In Tech, Inc. (HIT) stock forecast?
Our AI ranks Health In Tech, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Health In Tech, Inc. stock predictions?
A per-ticker accuracy statistic for HIT is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Health In Tech, Inc. forecasts updated?
Health In Tech, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Health In Tech, Inc.'s industry peers?
26 issuers in our coverage, HIT included, share the SEC industry code Insurance Agents, Brokers & Service. The largest are: Marsh & Mclennan Companies, Inc. (MRSH), Arthur J. Gallagher & Co. (AJG), Aon Plc (AON), Brown & Brown, Inc. (BRO), Equitable Holdings, Inc. (EQH), Erie Indemnity Co (ERIE).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.